Correlation Between Teva Pharmaceutical and CORONGLRES CDIS101

Can any of the company-specific risk be diversified away by investing in both Teva Pharmaceutical and CORONGLRES CDIS101 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharmaceutical and CORONGLRES CDIS101 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Teva Pharmaceutical Industries and CORONGLRES CDIS101, you can compare the effects of market volatilities on Teva Pharmaceutical and CORONGLRES CDIS101 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharmaceutical with a short position of CORONGLRES CDIS101. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharmaceutical and CORONGLRES CDIS101.

Diversification Opportunities for Teva Pharmaceutical and CORONGLRES CDIS101

-0.49

Correlation Coefficient

Teva Pharmaceutical  CORONGLRES CDIS101

Very good diversification

The 3 months correlation between Teva and CORONGLRES is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharmaceutical Industries and CORONGLRES CDIS101 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CORONGLRES CDIS101 and Teva Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharmaceutical Industries are associated (or correlated) with CORONGLRES CDIS101. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CORONGLRES CDIS101 has no effect on the direction of Teva Pharmaceutical i.e., Teva Pharmaceutical and CORONGLRES CDIS101 go up and down completely randomly.

Pair Corralation between Teva Pharmaceutical and CORONGLRES CDIS101

Assuming the 90 days horizon Teva Pharmaceutical Industries is expected to generate 1.29 times more return on investment than CORONGLRES CDIS101. However, Teva Pharmaceutical is 1.29 times more volatile than CORONGLRES CDIS101. It trades about 0.24 of its potential returns per unit of risk. CORONGLRES CDIS101 is currently generating about -0.22 per unit of risk. If you would invest  1,625  in Teva Pharmaceutical Industries on September 23, 2024 and sell it today you would earn a total of  495.00  from holding Teva Pharmaceutical Industries or generate 30.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.45%
Values	Daily Returns

Teva Pharmaceutical Industries  vs.  CORONGLRES CDIS101

Teva Pharmaceutical

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharmaceutical Industries are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Teva Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.

CORONGLRES CDIS101

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CORONGLRES CDIS101 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Teva Pharmaceutical and CORONGLRES CDIS101

The main advantage of trading using opposite Teva Pharmaceutical and CORONGLRES CDIS101 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharmaceutical position performs unexpectedly, CORONGLRES CDIS101 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CORONGLRES CDIS101 will offset losses from the drop in CORONGLRES CDIS101's long position.

The idea behind Teva Pharmaceutical Industries and CORONGLRES CDIS101 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.